News

The collaboration between Genzyme and the International Center for Genetic Engineering and Biotechnology (ICGEB) will initially focus on the development of new, improved treatments for malaria. ICGEB and

The pivotal Allegro study is designed to evaluate the efficacy, safety and tolerability of the oral investigational compound, laquinimod, versus placebo in the treatment of relapsing-remitting multiple sclerosis

The partnership of Patheon and Depomed unites the company’s proprietary AcuForm delivery technology with Patheon’s extensive network of manufacturing and distribution facilities across the globe. AcuForm is a

The first patient was enrolled by Eric Feldman at the Weill Medical College of Cornell University and New York Presbyterian Hospital. Dr Feldman was an investigator involved in

The OS12 was designed with gynecologists for use in abdominal hysterectomy. The IntelliSeal product line utilizes proprietary TissueSense technology in all of its electrosurgical instruments and systems. This

Galapagos’s service division BioFocus DPI will provide SoftFocus compounds for use in Merck Serono’s drug discovery programs. In a separate agreement, BioFocus DPI will perform medicinal chemistry services

This Phase II study is to explore the feasibility of developing NVC-422 as a product candidate to treat or prevent catheter-associated urinary tract infections (UTI). In this open-label

Investors included Foundation Capital, Lanza techVentures and various individuals. Concurrent with the financing, Adam Grosser, a general partner with Foundation Capital, has joined Numerate’s board of directors. Guido

The trial’s primary objective was to compare the efficacy of two doses of Bicifadine against placebo in reducing pain associated with diabetic neuropathy. The primary endpoint of the